Syon Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.34M Sell
3,447
-772
-18% -$326K 0.06% 250
2026
Q1
$2M Sell
4,219
-139
-3% -$70K 0.1% 148
2025
Q4
$2.03M Buy
4,358
+438
+11% +$203K 0.1% 151
2025
Q3
$1.67M Buy
3,920
+695
+22% +$269K 0.09% 151
2025
Q2
$1.24M Buy
3,225
+1,092
+51% +$393K 0.08% 174
2025
Q1
$737K Buy
2,133
+121
+6% +$38.9K 0.06% 235
2024
Q4
$604K Sell
2,012
-29
-1% -$10.1K 0.05% 246
2024
Q3
$830K Sell
2,041
-4
-0.2% -$1.46K 0.07% 199
2024
Q2
$657K Buy
2,045
+97
+5% +$31.5K 0.06% 216
2024
Q1
$650K Buy
1,948
+95
+5% +$29K 0.06% 225
2023
Q4
$502K Buy
1,853
+64
+4% +$15.8K 0.05% 252
2023
Q3
$440K Buy
+1,789
New +$490K 0.05% 201

Other funds holding HCA

Syon Capital's HCA Position: Q2 2026 in Review

Syon Capital reduced its HCA Healthcare (HCA) stake by 18% in Q2 2026, selling an estimated $326K and leaving 3,447 shares worth $1.34M. The position accounts for 0.06% of the portfolio, ranked #250.

Syon Capital first reported a position in HCA in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.03M in Q4 2025. 1,340 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Syon Capital held 3,447 shares of HCA Healthcare worth $1.34M as of Q2 2026.
  • Syon Capital sold 772 HCA Healthcare shares in Q2 2026, an estimated $326K.
  • HCA Healthcare made up 0.06% of Syon Capital's portfolio in Q2 2026, its #250 holding.
  • Syon Capital first reported a position in HCA Healthcare in Q3 2023 and has held it in 12 quarters since.
  • Syon Capital's HCA Healthcare position peaked at $2.03M in Q4 2025.
  • 1,340 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.